Astellas Pharma Inc. And Toyama Chemical Company Agree On Joint Development Of Quinolone Antibiotic T-3811 In Japan

January 30, 2006 |

1 min read

Twitter
LinkedIn
Facebook
Email
Print

Tokyo, Jan 27, 2006 (JCN) - Astellas Pharma and Toyama Chemical jointly announced on January 26 that they have reached a basic agreement to collaborate in the development and sales of T-3811, Toyama Chemical's proprietary agent, in Japan.

Twitter
LinkedIn
Facebook
Email
Print

Alliances Asia

Astellas Pharma US, Inc.